Price
$1347.11+9.20%Social Signal Score
Analyst Ratings
46 analysts52-week range
- Last close
- $1347.11
- Off 52w high
- -6.7%
- 200-day average
- $1117.90
- vs 200-day
- +20.5%
Revenue
$24.40B+323.52%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- David A. Ricks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 50,000
- Beta
- 0.45
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 9.09
Financials
Revenue
$24.40B+323.5%Net Income
$6.45B+735.8%EBITDA
$9.33B+624.3%Free Cash Flow
$8.22B+397.5%EPS (diluted)
$7.22+931.4%Shares Outstanding (diluted)
893.40M-18.8%Operating Expenses
$7.37BCash & Debt
$4.88BReturn of Capital
$1.92BRevenue by Segment (annual)
$65.18BDividend per Share
$1.73Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $65.18B | $20.64B | $23.07 |
| 2024 | $45.04B | $10.59B | $11.76 |
| 2023 | $34.12B | $5.24B | $5.83 |
| 2022 | $28.54B | $6.24B | $6.93 |
| 2021 | $28.32B | $5.58B | $6.15 |
| 2020 | $24.54B | $6.19B | $6.47 |
| 2019 | $22.32B | $8.32B | $8.69 |
| 2018 | $21.49B | $3.23B | $3.14 |
| 2017 | $19.97B | $-204.10M | $-0.19 |
| 2016 | $21.22B | $2.74B | $2.49 |
| 2015 | $19.96B | $2.41B | $2.18 |
| 2014 | $19.62B | $2.39B | $2.15 |
| 2013 | $23.11B | $4.68B | $4.19 |
| 2012 | $22.60B | $4.09B | $3.57 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from LLY's reported EPS growth of 15.4% a year over 13 years.
- EPS in 5 years
- $47.04
- Implied price
- $2,211
- Return from $1,347
- 10.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $1,099 — -18.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 33 | 40 | 47 | 54 | 61 |
|---|---|---|---|---|---|
| 5.4% | -6.0% | -2.4% | 0.8% | 3.7% | 6.2% |
| 10.4% | -1.6% | 2.3% | 5.6% | 8.6% | 11.3% |
| 15.4% | 2.9% | 6.9% | 10.4% | 13.5% | 16.3% |
| 20.4% | 7.3% | 11.5% | 15.2% | 18.4% | 21.4% |
| 25.4% | 11.8% | 16.2% | 20.0% | 23.4% | 26.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
20-50.00%Social Signal Score
Mentions (100)
- Newsfool.com·17h ago·Negative
$1,000 Invested in Eli Lilly 5 Years Ago Is Now Worth Over $5,000. Could It Soar That Much Again by 2031? Eli Lilly has seen revenue explode higher in recent years thanks to its dominance in the weight loss drug market. Its weight loss portfolio drove double-digit revenue growth in the recent quarter.
View source ↗ - News (RSS)seekingalpha·1d ago·Neutral
Key deals this week: PANW, FANG, ZS, LLY, and more
View source ↗ - Newsfool.com·1d ago·Neutral
Eli Lilly's Next Big Growth Opportunity Could Be Hiding in Plain Sight Zepbound helped adolescents lose substantial weight and improve key health measures in a clinical trial. Younger patients could open a meaningful new market for Eli Lilly's obesity franchise.
View source ↗ - 4chan /biz/biz·2d ago·Neutral
>>BUYAN NVDA, GLW, AEM, SKHY, CCJ, MSFT, closed some calls >>SELLAN >>HODLAN LLY, Maersk, Gold, Uranium s***, BTC (I'm not sure what a hodl is desu)
View source ↗ - 4chan /biz/biz·2d ago·Negative
do I sell LLY
View source ↗ - 4chan /biz/biz·2d ago·Negative
Now it makes sense >ARK's Autonomous Technology & Robotics ETF sold 33,430 shares of Nvidia Thursday, adding to Nvidia sales from earlier in the week. The block was worth $5,046,592 at Wednesday's $150.96 close. >ARK also sold 2,094 shares of Eli Lilly (NYSE:LLY) worth $2,895,478 and $4,088,500 of Ether and Solana staking ETFs. That points to ARK paying for part of the Anthropic purchase by selling down existing positions.
View source ↗ - 4chan /biz/biz·2d ago·Neutral
>>62933279 also adding to short CAVA, SG (this has been killing me) and ASTS. Staying long LLY, COST and PANW.
View source ↗ - 4chan /biz/biz·3d ago·Negative
>LLY down 2% IS NOTHING SACRED ANYMORE
View source ↗ - News247wallst.com·3d ago·Neutral
$1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth a Fortune Today One molecule turned a diversified drugmaker into a trillion-dollar giant, yet recent buyers have watched shares swing hard even as revenue surged. Does Lilly's next chapter justify today's price, or has the best part already happened?
View source ↗ - Newsseekingalpha.com·3d ago·Neutral
Eli Lilly: Everyone Losing Weight, But Lilly Keeps Gaining (Initiating With A Buy) Eli Lilly and Company earns a buy rating and a $1,600 target as volume growth outweighs pricing pressure and the pipeline advances. Q3 volume rose 53% despite 15% lower realized prices; management raised 2026 revenue guidance to $91–92 billion. Retatrutide's Phase 3 efficacy supports the next growth leg; LLY expects a Q1 2027 BLA, though regulatory and manufacturing risks remain.
View source ↗ - Newsreuters.com·4d ago·Negative
Weight-loss drugs' hit to UK grocery spending tops £1 billion, Worldpanel says The impact of weight-loss drugs on UK grocery spending has surpassed £1 billion ($1.32 billion), as new pill formats and rising uptake among men accelerate their use, researcher Worldpanel by Numerator said on Thursday.
View source ↗ - Newsbarrons.com·5d ago·Neutral
Eli Lilly Caught in Vendor Hack as Extortion Group Threatens to Leak Data on 1.2 Million Patients Lilly found no unauthorized access to its own systems, a person familiar with the matter said. Extortion group n0n claims to hold patient and prescriber data.
View source ↗ - 4chan /biz/biz·5d ago·Neutral
>>62915188 I hold KO and COKE. I hold LLY, TRV, PM. I hold real companies and I will never validate some d*******'s kid talking himself up on 4chan.
View source ↗ - 4chan /biz/biz·6d ago·Neutral
>>62912987 >>BUYING EUR (I was short) >>SELLING na >>HOLDING LLY, MEARSK, Gold, BTC >>EATING Water >>PLAYING na >>LISTENING TO Podcasts >>WATCHING na
View source ↗ - News (RSS)zerohedge·6d ago·Neutral
… for $2.15 billion in cash and 15.56 million shares, growing its position as one of the largest operators in the world’s most productive shale patch.Eli Lilly & Co. (LLY) inches about 1% higher after agreeing to buy Calytrix Bio, Inc. in a deal that could be worth up to $1.5 billion in the latest transaction by the acquisitive US drug company.Summit Therapeutics (SMMT) falls 12% after US regulators rejected the lung cancer treatment that the company and partner Akeso Inc. are developing.Take-Two…
View source ↗ - Newswsj.com·6d ago·Positive
Eli Lilly to Buy Calytrix Bio for Up to $1.5 Billion Calytrix Bio, a privately held biotechnology company backed by JPMorgan Chase, is developing therapies aimed at a group of rare blood cancers.
View source ↗ - Newsfool.com·7d ago·Negative
Prediction: $10,000 Equally Split Between Eli Lilly and Novo Nordisk Will Be Worth This Much by the End of 2027 Eli Lilly is surging, with revenue up 39% in the third quarter and a retatrutide filing planned for early 2027. Novo is bouncing back on oral Wegovy, with a CagriSema decision due soon.
View source ↗ - News (RSS)thestreet·8d ago·Positive
Nvidia CEO out — 10 stocks to buy before S&P 500 hits 8,000 Nvidia (NVDA) is down over 30% from the highs with CEO Jensen Huang stepping down, yet Blanke Schein Wealth Management CIO Robert Schein says the stock is still a buy. He also names Broadcom (AVGO), Apple (AAPL), and Eli Lilly (LLY) among his top picks before the S&P 500 reaches 8,000.
View source ↗ - 4chan /biz/biz·9d ago·Neutral
>>62901872 >>BUYAN NVDA, GLW, SKHY, CCJ >>SELLAN Not >>HODLAN LLY, MAERSK, Gold, My dick in a blender (BTC) >>PLAYAN Sometimes I visual playing my backlog in my brain >>WATCHAN Might watch Dune 2 >>LISTENAN https://www.youtube.com/watch?v=K3b6SGoN6dA >>READAN News >>EATAN Might order burger >>DRINKAN Water >>FAPPAN Not >>FEELAN Autistic
View source ↗ - Newsreuters.com·9d ago·Positive
Mapping the Market: Eli Lilly shares ready to rally again Mapping the Market: Eli Lilly shares ready to rally again
View source ↗ - News (RSS)zerohedge·10d ago·Neutral
…nditions in Brazil.Digi International (DGII) falls 18% after the communications software company’s first-quarter and full-year outlooks failed to impress. Eli Lilly (LLY) gains 2% after its China unit said Foundayo tablet was approved as a Class 1 new drug for adult weight managbioement by the country’s National Medical Products Administration, according to a WeChat statement. Maravai LifeSciences (MRVI) climbs 4% after KeyBanc upgraded the stock to overweight, saying the life sciences firm is b…
View source ↗ - 4chan /biz/biz·10d ago·Negative
>>62892787 LLY is going to make so many forever bagholders
View source ↗ - 4chan /biz/biz·10d ago·Neutral
>>62891901 I own real companies like LLY and Visa. You know, the ones that prey on fat degenerate addicts like yourself?
View source ↗ - 4chan /biz/biz·10d ago·Neutral
KO LLY V
View source ↗ - News (RSS)seekingalpha·11d ago·Neutral
4 stocks to watch on Wednesday: LLY, BABA, PYPL, and NVDA
View source ↗ - Newsbenzinga.com·11d ago·Negative
EXCLUSIVE: Lilly, Gilead Face Near-Term Drug Pricing Risks As Washington Turns Up Heat The next wave of U.S. drug-price negotiations could put billions of dollars in pharmaceutical revenue under pressure, with Eli Lilly and Co (NYSE:LLY), Gilead Sciences, Inc. (NASDAQ:GILD) facing more immediate exposure and Merck & Co‘s (NYSE:MRK) and Bristol-Myers Squibb Co‘s (NYSE:BMY) confronting a potentially bigger test in the years ahead.
View source ↗ - Newsprnewswire.com·11d ago·Negative
…esentation at ACR Convergence 2026 and simultaneously published in Arthritis & Rheumatology INDIANAPOLIS, Nov. 11, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed 52-week results showing improved and durable efficacy from the TOGETHER-PsA Phase 3b open-label clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone in adults with active psoriatic arthritis (PsA) and obesity or overweight with at least o…
View source ↗ - 4chan /biz/biz·11d ago·Neutral
>>62885348 you should have at least 2 more tickers do 25% BRKB 25% AMZN 25% TSM 25% LLY or more defensive 30% BRKB 30% AMZN 20% TSM 20% LLY But I would do 2 more ideally for 6 total so you're not absolutely f***** if two of them s*** the bed for years
View source ↗ - 4chan /biz/biz·12d ago·Positive
Sold my positions in LLY, BRKB, NVDA, and MCD. Made a solid 50k, thanks to buying LLY at 700~ Now I’ll wait and buy more VOO. Unless there’s a better gamble
View source ↗ - 4chan /biz/biz·13d ago·Neutral
>>62880660 >up 3.62% even with my big nvda bags Thanks LLY, thanks CEGs, even UUUU put in work today.
View source ↗ - 4chan /biz/biz·14d ago·Positive
>>62873809 Don't bother with biotech s******, no matter how much DD you do they're all coinflips at best. Just buy some LLY leaps, every person on earth will be taking retatrutide within 5 years and there's no downside because they are one of the largest health care cos on the planet with mature cancer and diabetes businesses.
View source ↗ - 4chan /biz/biz·14d ago·Neutral
>>62873809 IAM Google (isomorphic labs and verily) LLY
View source ↗ - Newsfool.com·16d ago·Negative
Eli Lilly Is Much More Than a Weight-Loss Drug Company. Here's the Evidence Some of Eli Lilly's products beyond its core therapeutic area are performing well. It also boasts a deep and diversified pipeline.
View source ↗ - 4chan /biz/biz·16d ago·Neutral
>>62869577 >>BUYAN AVGO, CCJ, CEG, GLW, NVDA, SKHY >>SELLAN No >>HODLAN AEM, GLD, LLY, BTC >>PLAYAN >>WATCHAN Stocks >>LISTENAN https://www.youtube.com/watch?v=mSAPD-Nk6p4&t=971s >>READAN Substacks >>EATAN Mushrooms >>DRINKAN Beer maybe idk >>FAPPAN Fat black butts >>FEELAN Hopium
View source ↗ - Newsprnewswire.com·16d ago·Positive
…patients a path to FDA-approved treatments at self-pay price through the Hims & Hers platform INDIANAPOLIS, Nov. 6, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Hims & Hers Health, Inc. (NYSE: HIMS) today announced an agreement to help expand access to Zepbound (tirzepatide) and Foundayo (orforglipron). Through the agreement, eligible patients who receive a prescription from a licensed provider on the Hims & Hers platform will access the same self-pay prices available to any patien…
View source ↗ - Newszacks.com·17d ago·Neutral
AI and Tech Selloff Heats Up: Buy Big Pharma Stock LLY as a Safe Haven? The massive AI-driven selloff is leaving investors looking for safe-haven stocks. Now might be a good time to consider buying Eli Lilly (LLY) stock for value and huge growth far outside of AI.
View source ↗ - 4chan /biz/biz·17d ago·Neutral
INVEST IN HEALTH CARE CHUDS. LLY
View source ↗ - Newszacks.com·17d ago·Neutral
4 Healthcare ETFs to Tap Into Eli Lilly's Post-Q3 Earnings Rally Eli Lilly's post-Q3 earnings rally highlights its surging drug demand. Discover 4 healthcare ETFs offering LLY exposure.
View source ↗ - 4chan /biz/biz·17d ago·Negative
>>62858968 I sold my SNDK. Lost five figures, but I guess they’ll help my taxes later with all the selling I did in the last couple weeks. At least LLY offset most of those losses. I posted that I should have bought a car to sleep in instead last week.
View source ↗ - News247wallst.com·17d ago·Negative
Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for Lilly Eli Lilly just crushed earnings and raised guidance, yet the most compelling part of its story has almost nothing to do with what already happened.
View source ↗ - 4chan /biz/biz·18d ago·Neutral
LLY TRV V KO PM
View source ↗ - Newsseekingalpha.com·18d ago·Positive
Eli Lilly: Higher Volume, Lower Realized Prices Eli Lilly and Company delivered 39% revenue growth, driven by 53% volume gains despite a 15% decline in realized prices; gross margin rose to 83.9%. Eli Lilly's Strong Buy rating reflects robust growth, high margins, and strong momentum, but earnings were impacted by $4.57/share in acquired R&D charges. Two-thirds of revenue comes from tirzepatide (Mounjaro/Zepbound), heightening concentration risk as patent expiration looms and pricing pressure in…
View source ↗ - 4chan /biz/biz·19d ago·Neutral
>>62851299 >LLY gang
View source ↗ - 4chan /biz/biz·19d ago·Neutral
comfy LLY
View source ↗ - 4chan /biz/biz·19d ago·Neutral
LLY, you are my shining star
View source ↗ - Newszacks.com·19d ago·Neutral
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - Newszacks.com·19d ago·Neutral
LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold? Eli Lilly and Company's LLY stock has risen 9.6% since it announced solid third-quarter results on Oct. 29. Lilly's third-quarter earnings and revenues comfortably exceeded estimates.
View source ↗ - News247wallst.com·19d ago·Negative
Eli Lilly Just Delivered Another Monster Quarter. But There's More to This Story Than Weight-Loss Drugs Eli Lilly's weight-loss drugs get all the headlines, but CEO David Ricks is betting the company's next act looks nothing like its last one. Here is what it would actually take for shares to reach $1,700 in 2027.
View source ↗ - Newsseekingalpha.com·20d ago·Neutral
…ns of cooling off in revenue growth now and in the forecast future. While margins are and can continue to remain solid, slowing revenue could impact them. Even then, LLY's attractive market multiples make a Buy case for the stock. Just not strong enough to make it as compelling a buy as it has been in recent months.
View source ↗ - News247wallst.com·20d ago·Neutral
Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year. Mounjaro and Zepbound just handed Lilly a blowout quarter, but falling realized drug prices and one-time revenue boosts that won't repeat raise real questions about whether the rally holds from here.
View source ↗ - 4chan /biz/biz·22d ago·Negative
>>62842705 its probably that same b**** from JPM that shorted PEP to a 5 year low because of "muh GLP 1 inhibitors muh LLY muh salty foods are obsolete" I hate that b**** like you wouldn't even believe
View source ↗ - Newsfool.com·22d ago·Neutral
After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock? Eli Lilly dominates the weight loss drug market and has a strong pipeline that may produce future winners. The company's stock has climbed amid optimism about this portfolio and its impact on earnings growth.
View source ↗ - News (RSS)fool·22d ago·Negative
Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030 GLP-1 weight loss drugs are propelling profits for some drugmakers like Eli Lilly.
View source ↗ - Newsfool.com·22d ago·Neutral
Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030 Eli Lilly stock has been on a tear, averaging annual gains of more than 30%. Future growth rates may not be quite so high, though.
View source ↗ - Newsmarketbeat.com·23d ago·Neutral
What Eli Lilly and Company (LLY) Said on Its Q3 Earnings Call Eli Lilly and Company NYSE: LLY raised its full-year outlook after reporting third-quarter revenue growth of 39% from the prior-year period, driven primarily by demand for its Mounjaro and Zepbound incretin medicines and continued growth across international markets.
View source ↗ - 4chan /biz/biz·23d ago·Neutral
>>62838062 >buy TRV and PM >sellll RTX SSO >hodlin LLY PM TRV V COP KO COKE BRK.B SCHD
View source ↗ - 4chan /biz/biz·23d ago·Neutral
LLY COP KO
View source ↗ - 4chan /biz/biz·23d ago·Neutral
>>62837676 >>BUYAN ANET, AVGO, CCJ, UUUU >>SELLAN CVX >>HODLAN LLY, AEM, GLD, MAERSK, BTC
View source ↗ - 4chan /biz/biz·23d ago·Neutral
ilu LLY ilu TOST ... NVDA
View source ↗ - 4chan /biz/biz·23d ago·Negative
When does LLY finally crash
View source ↗ - 4chan /biz/biz·23d ago·Negative
>>62836820 Buy companies that make money off of obese, elderly, and addicted people. LLY, KO, PM, TRV. Medicine, insurance, soda, drugs.
View source ↗ - 4chan /biz/biz·23d ago·Neutral
Bros, LLY. Also KO. Bet on diabetes.
View source ↗ - News247wallst.com·23d ago·Negative
Eli Lilly's Next Trillion-Dollar Opportunity May Go Beyond Weight-Loss Drugs Mounjaro and Zepbound built Lilly into a trillion-dollar company, but a surge in oncology, immunology, and neuroscience revenue hints that the real growth story is just getting started.
View source ↗ - Newszacks.com·23d ago·Neutral
LLY Q3 Earnings Call Highlights Raised Outlook and Obesity Drug Growth Eli Lilly raises its 2026 revenue outlook as Mounjaro and Zepbound sales surge, Medicare access expands and Foundayo gains traction despite pricing pressures.
View source ↗ - Newsseekingalpha.com·23d ago·Neutral
Eli Lilly: The Bar Just Got Higher Eli Lilly delivered standout 3Q26 results, with 39% revenue growth to $24.4B, driven by Mounjaro and Zepbound franchises. LLY's growth story is increasingly diversified, with Foundayo, Retatrutide, and the Medicare Bridge program offering additional revenue expansion paths. Management raised FY26 revenue guidance by $5.5B, but valuation remains demanding at 37.4x forward earnings and 13.5x forward sales.
View source ↗ - Newsseekingalpha.com·23d ago·Positive
Eli Lilly and Company (LLY) Q3 2026 Earnings Call Transcript Eli Lilly and Company ( LLY ) Q3 2026 Earnings Call October 29, 2026 10:00 AM EDT Company Participants Mike Czapar - Senior Vice President of Investor Relations David Ricks - Chairman, President & CEO Lucas Montarce - Executive VP & CFO Daniel Skovronsky - Chief Scientific & Product Officer and President of Lilly Research Laboratories Ilya Yuffa - Executive VP and President of Lilly USA & Global Customer Capabilities Carole Ho - Execut…
View source ↗ - 4chan /biz/biz·24d ago·Neutral
>>62831108 LLY PM V KO GRMN TRV
View source ↗ - Newsfool.com·24d ago·Negative
Eli Lilly Sells 53% More at Lower Prices: Rapid Earnings Reaction Eli Lilly's third-quarter revenue rose 39% to about $24.4 billion, as a 53% jump in volume more than offset a 15% drop in realized prices. Part of the quarter won't repeat, and deal charges are weighing on earnings.
View source ↗ - 4chan /biz/biz·24d ago·Neutral
>>62830309 Aren't you taking profits on LLY?
View source ↗ - 4chan /biz/biz·24d ago·Neutral
ily LLY ily TOST ... NVDA
View source ↗ - 4chan /biz/biz·24d ago·Neutral
>LLY >RTX >PM >V >TRV >COKE >SCHD Real world companies, brothers.
View source ↗ - 4chan /biz/biz·24d ago·Neutral
ily LLY
View source ↗ - Newsseekingalpha.com·24d ago·Negative
Eli Lilly: Mounjaro And Zepbound Keep The Growth Story Alive Eli Lilly and Company delivered solid third-quarter results. In Q3, LLY's non-GAAP EPS and revenue grew by 6.6% and 38.6% year-over-year, respectively. Mounjaro+Zepbound, Lilly's diabetes and obesity treatments, generated $16.08 billion in sales, reflecting 59.1% YoY growth.
View source ↗ - Newszacks.com·24d ago·Positive
Eli Lilly (LLY) Surpasses Q3 Earnings and Revenue Estimates Eli Lilly (LLY) came out with quarterly earnings of $7.48 per share, beating the Zacks Consensus Estimate of $5.38 per share. This compares to earnings of $7.02 per share a year ago.
View source ↗ - Newsinvezz.com·24d ago·Neutral
Eli Lilly's blowout quarter has a $5.5 billion twist Eli Lilly LLY reported better-than-expected earnings for its fiscal Q3 on Thursday, offering fresh evidence that helps justify its trillion-dollar market cap. Sales reached $24.4 billion, while adjusted earnings came in at $7.48.
View source ↗ - Newsbarrons.com·24d ago·Neutral
Eli Lilly Stock Jumps as Monster Earnings Powered by Mounjaro and Zepbound Eli Lilly posts earnings that handily top estimates, fueled by strong performance in its metabolic portfolio.
View source ↗ - Newsprnewswire.com·24d ago·Neutral
Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio Revenue in Q3 2026 increased 39% to $24.4 billion driven primarily by Mounjaro and Zepbound. Q3 revenue included approximately $900 million of benefits, primarily from $410 million of Jardiance milestones (no further milestones remain) and favorable adjustments to rebate and discount estimates.
View source ↗ - Newscnbc.com·24d ago·Negative
Eli Lilly is about to report earnings. Here's what to expect Eli Lilly is slated to report third-quarter earnings and revenue on Thursday. The results will likely be fueled by its blockbuster obesity drug Zepbound and diabetes counterpart Mounjaro.
View source ↗ - 4chan /biz/biz·24d ago·Neutral
>>62829141 nice. I just hedged LLY
View source ↗ - 4chan /biz/biz·24d ago·Positive
I decided to bless you guys with a free portfolio You can enter GOOGL, BRKB, AMZN, SPGI, GTT and ISRG today at fair valuations. Hold off on LLY, and TSM, or maybe don't hold off on TSM depending on how bullish you are. I would hold off on it. GOOGL 20% BRKB 20% AMZN 10% LLY 10% TSM 10% SPGI 10% GTT 10% ISRG 10% Don't bother if you can't have conviction in these companies.
View source ↗ - Newsinvestopedia.com·25d ago·Neutral
Here's How Much Eli Lilly Stock Is Expected to Move After Earnings Eli Lilly is set to report earnings Thursday morning, with traders expecting a move that could send the stock to a fresh high.
View source ↗ - Newsbenzinga.com·25d ago·Neutral
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings Eli Lilly and Company (NYSE:LLY) will release its third quarter earnings report before the opening bell on Thursday, Oct. 29.
View source ↗ - Newsreuters.com·26d ago·Negative
Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit Eli Lilly said on Tuesday that Patrik Jonsson, executive vice president and president of its international business, will retire at the end of 2026 after a 36-year career at the US drugmaker.
View source ↗ - 4chan /biz/biz·26d ago·Neutral
Here you go. Here is my primary portfolio. GOOGL 20% BRKB 20% AMZN 10% LLY 10% TSM 10% SPGI 10% GTT 10% ISRG 10%
View source ↗ - Newsprnewswire.com·27d ago·Negative
Lilly declares fourth-quarter 2026 dividend INDIANAPOLIS, Oct. 26, 2026 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2026 of $1.73 per share on outstanding common stock. The dividend is payable on December 10, 2026, to shareholders of record at the close of business on November 13, 2026.
View source ↗ - Newszacks.com·27d ago·Negative
LLY vs. MRK: Which Stock Offers the More Compelling Investment Case? Lilly and Merck boast blockbuster drugs, expanding pipelines and new growth opportunities but pricing pressure, patent risks & competition shape their outlooks.
View source ↗ - Newszacks.com·27d ago·Neutral
Lilly (LLY) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Lilly (LLY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
View source ↗ - News247wallst.com·28d ago·Positive
3 Massive Catalysts That Could Ignite an Eli Lilly Stock Rally on Oct 29 Eli Lilly (NYSE:LLY | LLY Price Prediction) reports third-quarter results on October 29. It brings a streak of 5 consecutive EPS beats and a stock that has run hard into the report.
View source ↗ - Newsdefenseworld.net·29d ago·Negative
Eli Lilly and Company $LLY Shares Sold by Essential Planning LLC. Essential Planning LLC. cut its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 93.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 187 shares of the company's stock after selling 2,663 shares during the
View source ↗ - Newsdefenseworld.net·29d ago·Negative
7,473 Eli Lilly and Company $LLY Shares Sold by Halter Ferguson Financial Inc. Halter Ferguson Financial Inc. trimmed its position in Eli Lilly and Company (NYSE: LLY) by 90.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 814 shares of the company's stock after selling 7,473 shares during the
View source ↗ - Newsyoutube.com·29d ago·Negative
Eli Lilly CEO previews the next generation of weight-loss drugs Eli Lilly chair and CEO Dave Ricks discusses the company's expansion and 150th year in business on ‘Claman's Power Players.' #fox #foxbusiness #media #breakingnews #us #usa #new #news #breaking #clamanspowerplayers #lizclaman #claman #elililly #davericks #ricks #weightloss #weightlossdrugs #obesity #obesitytreatment #glp1 #pharmaceuticals #pharma #pharmaceuticalindustry #healthcare #healthcareinnovation #drugdevelopment #artificiali
View source ↗ - News (RSS)thestreet·30d ago·Positive
Goldman Sachs resets Eli Lilly 12-month stock price target before earnings Wall Street expects strong numbers from LLY, but Goldman says one figure will decide the reaction.
View source ↗ - Newsgurufocus.com·30d ago·Negative
Eli Lilly Stocks Slip 1.7% Ahead of Earnings After 48% Revenue Growth Diabetes and obesity-drug maker Eli Lilly (LLY) traded at $1,284.51, down approximately 1.70% at 10.09am EST, on October 23. With earnings due next Thursday, ac
View source ↗ - Newsdefenseworld.net·30d ago·Negative
Eli Lilly and Company $LLY Stock: Carnegie Investment Counsel Increases Stake Carnegie Investment Counsel boosted its position in shares of Eli Lilly and Company (NYSE: LLY) by 46.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,281 shares of the company's stock after acquiring an additional 5,167 shares
View source ↗ - News (RSS)fool·30d ago·Neutral
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026? Amgen trades at half the valuation multiple of Eli Lilly while generating stronger free cash flow, but explosive growth in obesity drugs tells a different story.
View source ↗ - 4chan /biz/biz·31d ago·Neutral
…PI. That's your cheat sheet. >it's red Check oil. >above $110 Check news about middle-east. >s*** got blown up Expect semis to go down. Look up defensives like P&G & LLY to see if you can gain something for the day. >it's green Look up if there's news about peace talks and s***. >check if oil is below $110 Look up if defensives are falling in overnight/pre-market and semis on the rise. >expect a V or fake V, don't buy in the first ~15-30 minutes after it goes live There will be some profit taki…
View source ↗ - 4chan /biz/biz·31d ago·Positive
I also love you LLY. And my GEV is completely and totally gaped. I'm gonna buy more.
View source ↗ - 4chan /biz/biz·31d ago·Neutral
ilu LLY
View source ↗ - 4chan /biz/biz·31d ago·Neutral
>>62804412 >LLY im grateful to lly for permanently ending my depression and my libido
View source ↗ - 4chan /biz/biz·31d ago·Neutral
>>62804399 GEV, LLY, TRV, GRMN
View source ↗
Earnings
Wed, Feb 3(in 2 months)
Consensus estimate $11.23 per share
Typical surprise +22.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Oct 29$7.48 vs $5.71beat
- Wed, Aug 5$8.38 vs $6.40beat
- Thu, Apr 30$8.55 vs $6.97beat
- Wed, Feb 4$7.54 vs $6.91beat
- Thu, Oct 30$7.02 vs $5.69beat
- Thu, Aug 7$6.31 vs $5.60beat
Estimates and results for LLY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by LLY officers and directors.
- Bought
- —
- Sold
- $41.6m
0 trades
7 trades
- Hakim Anatsold
- Jonsson Patriksold
- Zakrowski Donald Asold
- Hakim Anatsold
- Yuffa Ilyasold
- Lilly Endowment Incsold
- Lilly Endowment Incsold
93 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Michael Rullihouse · OH06 · disclosed Nov 18, 2026 (14d later)Sell$1,001 - $15,000
- David Taylorhouse · OH02 · disclosed Nov 13, 2026 (10d later)Sell$1,001 - $15,000
- David Taylorhouse · OH02 · disclosed Nov 13, 2026 (10d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Nov 10, 2026 (21d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (35d later)Buy$1,001 - $15,000
- John Boozmansenate · AR · disclosed Aug 24, 2026 (276d later)Sell$1,001 - $15,000
- Michael Rullihouse · disclosed Aug 10, 2026 (220d later)Buy$1,001 - $15,000
- Michael Rullihouse · disclosed Aug 10, 2026 (251d later)Sell$1,001 - $15,000
- Michael Rullihouse · disclosed Aug 10, 2026 (40d later)Sell$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Aug 5, 2026 (477d later)Sell$15,001 - $50,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Sell$1,001 - $15,000
- Daniel Milton Newhousehouse · WA04 · disclosed Jul 20, 2026 (10d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2026 (36d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Jul 3, 2026 (23d later)Buy$50,001 - $100,000
- Byron Donaldshouse · FL19 · disclosed May 14, 2026 (42d later)Buy$1,001 - $15,000
- Byron Donaldshouse · FL19 · disclosed May 14, 2026 (42d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed May 11, 2026 (27d later)Buy$1,001 - $15,000
- Elizabeth Pannill Fletcherhouse · disclosed May 1, 2026 (23d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Apr 8, 2026 (26d later)Sell$1,001 - $15,000
- Angus Kingsenate · ME · disclosed Mar 24, 2026 (39d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
